Neil D. Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neil D. Almeida has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Dheerendra Prasad
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo
11 shared publications - Victor Goulenko
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA
10 shared publications - Venkatesh Shankar Madhugiri
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA
9 shared publications - Sarthak Sinha
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo
8 shared publications - Robert A. Fenstermaker
Department of Neurosurgery, Roswell Park Comprehensive Cancer Center, Buffalo, USA
5 shared publications - Rohil Shekher
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
5 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 180 (2)
Does timing matter? Early postoperative Gamma Knife radiosurgery within 14 days is associated with longer overall survival after brain metastasis resection
Background: The optimal timing of postoperative Gamma Knife radiosurgery (GKRS) following brain metastasis resection remains uncertain. We evaluated the association between surgery-to-GKRS timing and overall survival (OS) and local recurrence-free survival (LRFS). Methods: We retrospectively analyzed 182 patients who underwent initial postoperative cavity-directed GKRS following brain metastasis resection between May 2007 through February 2025. Surgery-to-GKRS timing was evaluated continuously and using outcome-oriented cutpoint analysis across intervals of 7–60 days. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox regression, with additional sensitivity analyses evaluating cutpoint stability and potential confounding. Results: The median surgery-to-GKRS interval was 19.5 days. Treatment within 14 days demonstrated the greatest observed OS separation, with median survival of 37.8 versus 15.3 months for patients treated later (log-rank p = 0.0123). This association persisted after multivariable adjustment (HR 0.62, 95% CI 0.38–1.00; p = 0.0491) and additional adjustment for calendar year of surgery (HR 0.60, 95% CI 0.37–0.97; p = 0.037). However, the 14-day threshold did not retain statistical significance after adjustment for outcome-oriented cutpoint selection ( p = 0.181). GKRS timing was not significantly associated with LRFS. Conclusions: GKRS within 14 days of brain metastasis resection was associated with substantially longer overall survival, highlighting the potential clinical importance of timely postoperative radiosurgical care. Although the optimal treatment interval remains uncertain, these findings support early referral, efficient multidisciplinary coordination, and minimizing avoidable treatment delays.
- 11 November 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 180 (2)
Open AccessDoes timing matter? Early postoperative Gamma Knife radiosurgery within 14 days is associated with longer overall survival after brain metastasis resection
Background: The optimal timing of postoperative Gamma Knife radiosurgery (GKRS) following brain metastasis resection remains uncertain. We evaluated the association between surgery-to-GKRS timing and overall survival (OS) and local recurrence-free survival (LRFS). Methods: We retrospectively analyzed 182 patients who underwent initial postoperative cavity-directed GKRS following brain metastasis resection between May 2007 through February 2025. Surgery-to-GKRS timing was evaluated continuously and using outcome-oriented cutpoint analysis across intervals of 7–60 days. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox regression, with additional sensitivity analyses evaluating cutpoint stability and potential confounding. Results: The median surgery-to-GKRS interval was 19.5 days. Treatment within 14 days demonstrated the greatest observed OS separation, with median survival of 37.8 versus 15.3 months for patients treated later (log-rank p = 0.0123). This association persisted after multivariable adjustment (HR 0.62, 95% CI 0.38–1.00; p = 0.0491) and additional adjustment for calendar year of surgery (HR 0.60, 95% CI 0.37–0.97; p = 0.037). However, the 14-day threshold did not retain statistical significance after adjustment for outcome-oriented cutpoint selection ( p = 0.181). GKRS timing was not significantly associated with LRFS. Conclusions: GKRS within 14 days of brain metastasis resection was associated with substantially longer overall survival, highlighting the potential clinical importance of timely postoperative radiosurgical care. Although the optimal treatment interval remains uncertain, these findings support early referral, efficient multidisciplinary coordination, and minimizing avoidable treatment delays.
- Open Access
- 9 November 2026
- Published by Elsevier in Advances in Radiation Oncology
Clinical Outcomes After Proton Craniospinal Irradiation for Leptomeningeal Disease: A Systematic Review and Single-Arm Meta-Analysis
- 9 November 2026
- Published by Elsevier in Advances in Radiation Oncology
Open AccessClinical Outcomes After Proton Craniospinal Irradiation for Leptomeningeal Disease: A Systematic Review and Single-Arm Meta-Analysis
- Open Access
- 3 July 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 178 (3) , 87
Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors
Background: Brain metastases from renal cell carcinoma (RCC) are uncommon but clinically consequential. We evaluated survival, intracranial failure, lesion-level local failure, and MRI volumetric response after Gamma Knife radiosurgery (GKRS), including associations with systemic therapy exposure. Methods: We retrospectively identified patients treated with GKRS for intracranial RCC metastases (2001–2025). Systemic therapy exposure (TKI and/or immunotherapy) was captured time-agnostically. Overall survival (OS) and patient-level intracranial treatment failure were analyzed using Kaplan–Meier/Cox models. Lesion-level treatment failure was analyzed using clustered generalized estimating equations (GEE). Six-month volumetric response was assessed using an epsilon-stabilized log volume ratio ln{(V 6m +ϵ)/(V GKRS +ϵ)}, ε = 0.01. Results: Thirty-four patients (87 lesions) were treated; 22 deaths occurred. Overall survival was numerically longer among patients who received systemic therapy compared with those who did not, although this did not reach statistical significance (log-rank p = 0.058). In a parsimonious adjusted Cox model, TKI exposure was associated with improved OS (aHR 0.191; 95% CI 0.062–0.593; p = 0.004), as was higher KPS (HR 0.37 per 10-point increase; 95% CI 0.21–0.63; p < 0.001). Ten patient-level intracranial treatment failure events occurred, without significant differences by systemic therapy exposure. At the lesion level, 15/87 lesions failed; postoperative cavities had higher failure than intact lesions (71.4% vs. 12.5%; p = 0.001) and remained associated with failure after clustered adjustment (OR 9.92; 95% CI 1.44–68.27; p = 0.020). Dmax was not correlated with 6-month log volume ratio (ρ=−0.075; p = 0.535), but poorer 6-month volumetric response was associated with subsequent lesion failure ( p = 0.0023; clustered OR 2.84; 95% CI 1.16–6.96; p = 0.023). Conclusions: In RCC brain metastases treated with GKRS, postoperative cavities showed a higher observed rate of local failure than intact lesions, although this finding should be interpreted cautiously given the small number of cavity targets. While Dmax was not associated with early volumetric change, early 6-month volumetric trajectory was associated with subsequent local failure, suggesting a pragmatic imaging marker for risk-adapted surveillance and salvage planning. Systemic therapy exposure, particularly TKIs, was associated with OS in adjusted analysis, whereas intracranial treatment failure did not differ by systemic exposure in this cohort.
- 3 July 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 178 (3) , 87
Open AccessGamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors
Background: Brain metastases from renal cell carcinoma (RCC) are uncommon but clinically consequential. We evaluated survival, intracranial failure, lesion-level local failure, and MRI volumetric response after Gamma Knife radiosurgery (GKRS), including associations with systemic therapy exposure. Methods: We retrospectively identified patients treated with GKRS for intracranial RCC metastases (2001–2025). Systemic therapy exposure (TKI and/or immunotherapy) was captured time-agnostically. Overall survival (OS) and patient-level intracranial treatment failure were analyzed using Kaplan–Meier/Cox models. Lesion-level treatment failure was analyzed using clustered generalized estimating equations (GEE). Six-month volumetric response was assessed using an epsilon-stabilized log volume ratio ln{(V 6m +ϵ)/(V GKRS +ϵ)}, ε = 0.01. Results: Thirty-four patients (87 lesions) were treated; 22 deaths occurred. Overall survival was numerically longer among patients who received systemic therapy compared with those who did not, although this did not reach statistical significance (log-rank p = 0.058). In a parsimonious adjusted Cox model, TKI exposure was associated with improved OS (aHR 0.191; 95% CI 0.062–0.593; p = 0.004), as was higher KPS (HR 0.37 per 10-point increase; 95% CI 0.21–0.63; p < 0.001). Ten patient-level intracranial treatment failure events occurred, without significant differences by systemic therapy exposure. At the lesion level, 15/87 lesions failed; postoperative cavities had higher failure than intact lesions (71.4% vs. 12.5%; p = 0.001) and remained associated with failure after clustered adjustment (OR 9.92; 95% CI 1.44–68.27; p = 0.020). Dmax was not correlated with 6-month log volume ratio (ρ=−0.075; p = 0.535), but poorer 6-month volumetric response was associated with subsequent lesion failure ( p = 0.0023; clustered OR 2.84; 95% CI 1.16–6.96; p = 0.023). Conclusions: In RCC brain metastases treated with GKRS, postoperative cavities showed a higher observed rate of local failure than intact lesions, although this finding should be interpreted cautiously given the small number of cavity targets. While Dmax was not associated with early volumetric change, early 6-month volumetric trajectory was associated with subsequent local failure, suggesting a pragmatic imaging marker for risk-adapted surveillance and salvage planning. Systemic therapy exposure, particularly TKIs, was associated with OS in adjusted analysis, whereas intracranial treatment failure did not differ by systemic exposure in this cohort.
- Open Access
- 1 July 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 152, 112173
Tumor control and cranial nerve outcomes after Gamma Knife radiosurgery for Glomus jugulare tumors: a systematic review, meta-analysis, and institutional failure pattern analysis
- 1 July 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 152, 112173
Open AccessTumor control and cranial nerve outcomes after Gamma Knife radiosurgery for Glomus jugulare tumors: a systematic review, meta-analysis, and institutional failure pattern analysis
- Open Access
- 28 April 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 177 (3) , 129
Longitudinal remodeling of brain metastasis resection cavities after adjuvant gamma knife radiosurgery
Purpose: Postoperative Gamma Knife Radiosurgery (GKRS) to resection cavities is standard for intracranial metastases, but the dynamics of these cavities after treatment and their relationship to local control remain incompletely defined. Methods: We retrospectively reviewed 98 patients with 98 resection cavities treated with single- or hypofractionated Gamma Knife radiosurgery (GKRS) between 2011 and 2025. Cavity volumes were segmented from serial contrast-enhanced MRI and compared with GKRS planning volumes. Longitudinal changes in log-transformed volumes were modeled using linear mixed-effects regression. Local recurrence–free survival (LRFS) and overall survival (OS) were estimated using Kaplan–Meier analysis, and associations with outcomes were tested using Cox proportional hazards models. Results: Median imaging follow-up was 9.1 months (IQR 4.9–16.5), and cavities showed significant volume reduction over time (β = −0.031 ln[cc]/month, p < 0.001). Modeling indicated a nonlinear pattern, with greater reduction early and relative stabilization thereafter. At 12 and 24 months, actuarial local control was 74.5% and 62.5%, respectively; median LRFS was 49.8 months. Volume regression occurred in both recurrent and non-recurrent groups, and the interaction between recurrence status and time was nonsignificant. Recurrence rates did not differ between single- and hypofractionated GKRS across preoperative volume strata. Higher Karnofsky performance status at surgery and at GKRS correlated with improved OS and smaller cavity volumes. Conclusions: Cavities treated with GKRS showed consistent involution over time, most pronounced early after treatment. Volumetric change alone was not associated with local control; interpretation of local failure requires dosimetric and target-definition context.
- 28 April 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 177 (3) , 129
Open AccessLongitudinal remodeling of brain metastasis resection cavities after adjuvant gamma knife radiosurgery
Purpose: Postoperative Gamma Knife Radiosurgery (GKRS) to resection cavities is standard for intracranial metastases, but the dynamics of these cavities after treatment and their relationship to local control remain incompletely defined. Methods: We retrospectively reviewed 98 patients with 98 resection cavities treated with single- or hypofractionated Gamma Knife radiosurgery (GKRS) between 2011 and 2025. Cavity volumes were segmented from serial contrast-enhanced MRI and compared with GKRS planning volumes. Longitudinal changes in log-transformed volumes were modeled using linear mixed-effects regression. Local recurrence–free survival (LRFS) and overall survival (OS) were estimated using Kaplan–Meier analysis, and associations with outcomes were tested using Cox proportional hazards models. Results: Median imaging follow-up was 9.1 months (IQR 4.9–16.5), and cavities showed significant volume reduction over time (β = −0.031 ln[cc]/month, p < 0.001). Modeling indicated a nonlinear pattern, with greater reduction early and relative stabilization thereafter. At 12 and 24 months, actuarial local control was 74.5% and 62.5%, respectively; median LRFS was 49.8 months. Volume regression occurred in both recurrent and non-recurrent groups, and the interaction between recurrence status and time was nonsignificant. Recurrence rates did not differ between single- and hypofractionated GKRS across preoperative volume strata. Higher Karnofsky performance status at surgery and at GKRS correlated with improved OS and smaller cavity volumes. Conclusions: Cavities treated with GKRS showed consistent involution over time, most pronounced early after treatment. Volumetric change alone was not associated with local control; interpretation of local failure requires dosimetric and target-definition context.
- 25 March 2026
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
Skull Base Meningiomas with Extracranial Extension: Outcomes and Patterns of Failure after Radiosurgery in the Primary or Adjuvant Settings, and a Multidisciplinary Management Algorithm
Meningiomas are typically benign extra-axial tumors treated with surgery or radiosurgery, but extracranial extension from skull base lesions is rare and poorly defined. This study reports outcomes of stereotactic radiosurgery for skull base meningiomas with extracranial extension, focusing on tumor control, clinical outcomes, and patterns of failure. We conducted a retrospective single-institution review of patients treated with gamma knife radiosurgery (GKRS) for skull base meningiomas with extracranial extension. Clinical, radiographic, and treatment variables—including extension patterns, cranial nerve involvement, and dosimetry—were analyzed. Tumor control and symptom outcomes were assessed using univariate and multivariable analyses. Kaplan–Meier and Cox regression analyses compared primary versus salvage GKRS. A management algorithm was developed based on a literature review. Thirty-four patients were included: 13 treated with primary GKRS and 21 with salvage GKRS after prior treatment. The most common extracranial extension sites were the pterygopalatine fossa and orbit, and visual changes were the most frequent symptom. Symptomatic deterioration was associated with larger tumor volume, higher maximum dose, foraminal extension, female sex, and prior treatment. Hyperostosis, prior treatment, and higher histologic grade predicted retreatment. At the last follow-up, over 90% of patients achieved radiographic tumor control and symptom stability. Primary GKRS was associated with fewer complications and better tumor control than salvage treatment. GKRS provides durable tumor control and favorable clinical outcomes for selected skull base meningiomas with extracranial extension. When feasible, primary radiosurgery may be preferable to salvage therapy. Predominant intracranial marginal progression supports targeted surveillance and a multidisciplinary, risk-adapted management strategy.
- 25 March 2026
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
Skull Base Meningiomas with Extracranial Extension: Outcomes and Patterns of Failure after Radiosurgery in the Primary or Adjuvant Settings, and a Multidisciplinary Management Algorithm
Meningiomas are typically benign extra-axial tumors treated with surgery or radiosurgery, but extracranial extension from skull base lesions is rare and poorly defined. This study reports outcomes of stereotactic radiosurgery for skull base meningiomas with extracranial extension, focusing on tumor control, clinical outcomes, and patterns of failure. We conducted a retrospective single-institution review of patients treated with gamma knife radiosurgery (GKRS) for skull base meningiomas with extracranial extension. Clinical, radiographic, and treatment variables—including extension patterns, cranial nerve involvement, and dosimetry—were analyzed. Tumor control and symptom outcomes were assessed using univariate and multivariable analyses. Kaplan–Meier and Cox regression analyses compared primary versus salvage GKRS. A management algorithm was developed based on a literature review. Thirty-four patients were included: 13 treated with primary GKRS and 21 with salvage GKRS after prior treatment. The most common extracranial extension sites were the pterygopalatine fossa and orbit, and visual changes were the most frequent symptom. Symptomatic deterioration was associated with larger tumor volume, higher maximum dose, foraminal extension, female sex, and prior treatment. Hyperostosis, prior treatment, and higher histologic grade predicted retreatment. At the last follow-up, over 90% of patients achieved radiographic tumor control and symptom stability. Primary GKRS was associated with fewer complications and better tumor control than salvage treatment. GKRS provides durable tumor control and favorable clinical outcomes for selected skull base meningiomas with extracranial extension. When feasible, primary radiosurgery may be preferable to salvage therapy. Predominant intracranial marginal progression supports targeted surveillance and a multidisciplinary, risk-adapted management strategy.
- Open Access
- 23 January 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 35
Radiation-induced meningiomas: A systematic review and meta-analysis of 927 meningiomas
Background: Meningiomas are the most common intracranial tumor. Ionizing radiation has been implicated in the pathogenesis of radiation-induced meningiomas (RIM). Compared to spontaneous meningiomas, RIM are a clinically aggressive entity and are more likely to develop clinical and radiologic progression. Methods: Systematic searches of Medline, Embase, and Cochrane Central Register of Controlled Trials were performed. Pooled data were used to calculate rates of survival, tumor control, and adverse events. Results: Thirty studies met the final inclusion criterion within this meta-analysis. In total, these studies reported on 927 RIMs in 825 patients. Patients were grouped by whether they received cranial radiotherapy ([CRT]; n = 555 patients) or scalp radiotherapy for tinea capitis ([TC]; n = 270 patients). The median dose prescribed to the CRT and TC groups was ~30 Gy and 1.5 Gy, respectively. The radiation interval to meningioma development between CRT and TC groups were 21.54 and 40.49 years, respectively ( P < 0.0001). Twenty-six studies reported a 1-year overall survival rate, with a pooled survival rate of 95.46% (95% confidence interval [CI]: 92.31–97.82%, I2 = 51.9%, P = 0.0012). One-year progression-free survival was reported by 9 studies, with a pooled rate of 99.71% (95% CI: 97.62–100.00%, I 2 = 3.3%, P = 0.4076). From two studies, the pooled 1-year local recurrence rate was 16.54% (95% CI: 0.00–34.06%, I 2 = 0.0%, P = 0.5918), while the overall pooled local recurrence rate was 27.35% (95% CI: 17.98–36.73%, I 2 = 74.5%, P < 0.0001) from 23 studies. Conclusion: High- and low-dose cranial radiation therapy can differentially influence the latency and grade of RIM, with higher dose CRT associated with earlier onset and more atypical tumors RIM screening may be warranted in individuals with an early exposure to cranial radiation given the increased risk of developing secondary neoplasms. These findings support structured long-term magnetic resonance imaging surveillance for survivors of childhood cranial irradiation, with risk adapted follow-up protocols to enable earlier detection and management.
- 23 January 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 35
Open AccessRadiation-induced meningiomas: A systematic review and meta-analysis of 927 meningiomas
Background: Meningiomas are the most common intracranial tumor. Ionizing radiation has been implicated in the pathogenesis of radiation-induced meningiomas (RIM). Compared to spontaneous meningiomas, RIM are a clinically aggressive entity and are more likely to develop clinical and radiologic progression. Methods: Systematic searches of Medline, Embase, and Cochrane Central Register of Controlled Trials were performed. Pooled data were used to calculate rates of survival, tumor control, and adverse events. Results: Thirty studies met the final inclusion criterion within this meta-analysis. In total, these studies reported on 927 RIMs in 825 patients. Patients were grouped by whether they received cranial radiotherapy ([CRT]; n = 555 patients) or scalp radiotherapy for tinea capitis ([TC]; n = 270 patients). The median dose prescribed to the CRT and TC groups was ~30 Gy and 1.5 Gy, respectively. The radiation interval to meningioma development between CRT and TC groups were 21.54 and 40.49 years, respectively ( P < 0.0001). Twenty-six studies reported a 1-year overall survival rate, with a pooled survival rate of 95.46% (95% confidence interval [CI]: 92.31–97.82%, I2 = 51.9%, P = 0.0012). One-year progression-free survival was reported by 9 studies, with a pooled rate of 99.71% (95% CI: 97.62–100.00%, I 2 = 3.3%, P = 0.4076). From two studies, the pooled 1-year local recurrence rate was 16.54% (95% CI: 0.00–34.06%, I 2 = 0.0%, P = 0.5918), while the overall pooled local recurrence rate was 27.35% (95% CI: 17.98–36.73%, I 2 = 74.5%, P < 0.0001) from 23 studies. Conclusion: High- and low-dose cranial radiation therapy can differentially influence the latency and grade of RIM, with higher dose CRT associated with earlier onset and more atypical tumors RIM screening may be warranted in individuals with an early exposure to cranial radiation given the increased risk of developing secondary neoplasms. These findings support structured long-term magnetic resonance imaging surveillance for survivors of childhood cranial irradiation, with risk adapted follow-up protocols to enable earlier detection and management.
- Open Access
- 13 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (6) , 1402-1412
Early Initiation of Radiation Therapy Improves Survival in Elderly Patients With Glioblastoma
BACKGROUND AND OBJECTIVES: To study the impact of early initiation of radiation therapy (RT) in elderly patients with newly diagnosed glioblastoma. METHODS: A total of 56 elderly patients (aged 65 and older) diagnosed with isocitrate dehydrogenase (IDH)-wildtype glioblastoma were analyzed from a prospective registry from 2020 to 2024. Survival analysis was conducted to evaluate the impact of timing of RT initiation after surgical resection on survival outcomes. A specific cutoff point for RT initiation was evaluated using the log-rank test, with P -values adjustment for multiple comparisons using the false discovery rate approach. Kaplan-Meier curves were used to illustrate survival distributions. Associations of various risk factors with survival were initially examined through univariate Cox regression models, followed by multivariate analysis to assess the combined effects of these factors. The results were reported as hazard ratios with 95% CIs. RESULTS: Elderly patients with glioblastoma who underwent initiation of RT < 20 days from date of surgery demonstrated improved overall survival (OS) ( P = .0460) and progression-free survival (PFS) ( P = .0075) in our cohort. Multivariate analysis demonstrated that adjuvant temozolomide significantly affected both OS ( P = .0038) and PFS ( P = .0133). Conventionally fractionated RT consisting of 60 Gy in 30 fractions demonstrated significantly improved PFS ( P = .0164) in patients who underwent early initiation of RT (P = .0509) in patients who underwent early initiation of RT (<20 days). CONCLUSION: Early initiation of RT in elderly patients with newly diagnosed glioblastoma improves both OS and progression-free survival. Timing of RT is particularly of significance in this patient population who may not be optimal candidates for systemic chemotherapy.
- 13 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (6) , 1402-1412
Open AccessEarly Initiation of Radiation Therapy Improves Survival in Elderly Patients With Glioblastoma
BACKGROUND AND OBJECTIVES: To study the impact of early initiation of radiation therapy (RT) in elderly patients with newly diagnosed glioblastoma. METHODS: A total of 56 elderly patients (aged 65 and older) diagnosed with isocitrate dehydrogenase (IDH)-wildtype glioblastoma were analyzed from a prospective registry from 2020 to 2024. Survival analysis was conducted to evaluate the impact of timing of RT initiation after surgical resection on survival outcomes. A specific cutoff point for RT initiation was evaluated using the log-rank test, with P -values adjustment for multiple comparisons using the false discovery rate approach. Kaplan-Meier curves were used to illustrate survival distributions. Associations of various risk factors with survival were initially examined through univariate Cox regression models, followed by multivariate analysis to assess the combined effects of these factors. The results were reported as hazard ratios with 95% CIs. RESULTS: Elderly patients with glioblastoma who underwent initiation of RT < 20 days from date of surgery demonstrated improved overall survival (OS) ( P = .0460) and progression-free survival (PFS) ( P = .0075) in our cohort. Multivariate analysis demonstrated that adjuvant temozolomide significantly affected both OS ( P = .0038) and PFS ( P = .0133). Conventionally fractionated RT consisting of 60 Gy in 30 fractions demonstrated significantly improved PFS ( P = .0164) in patients who underwent early initiation of RT (P = .0509) in patients who underwent early initiation of RT (<20 days). CONCLUSION: Early initiation of RT in elderly patients with newly diagnosed glioblastoma improves both OS and progression-free survival. Timing of RT is particularly of significance in this patient population who may not be optimal candidates for systemic chemotherapy.
- Open Access
- 27 August 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 141, 111587
Hypofractionated vs. single-session Gamma Knife radiosurgery for orbital cavernous hemangiomas: A systematic review, meta-analysis, and institutional case series
- 27 August 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 141, 111587
Open AccessHypofractionated vs. single-session Gamma Knife radiosurgery for orbital cavernous hemangiomas: A systematic review, meta-analysis, and institutional case series
- Open Access
Association of Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement with Unplanned Hospitalization for Head and Neck Cancer
Background/Objectives: There is a varying need for nutritional support among head and neck cancer (HNC) patients. Unplanned hospitalization is frequent with definitive chemoradiation. However, the association of unplanned hospitalizations with cancer control outcomes and percutaneous endoscopic gastrostomy (PEG) tube placement is not well-understood. This study aims to evaluate the clinical outcomes stratified by unplanned hospitalizations and to identify the prognostic factors associated with unplanned hospitalizations. Methods: This retrospective cohort study included 657 HNC patients treated with definitive chemoradiation at a single institution between 2007 and 2023. Relevant clinical data were evaluated for unplanned hospitalizations, prophylactic vs. therapeutic PEG tube placement, and clinical outcomes. Multivariable, subgroup, and matched-pair analyses were performed to account for potential confounding variables. The main outcomes and measures used are overall survival (OS), progression-free survival (PFS), locoregional failure (LRF), distant failure (DF), and incidence of unplanned hospitalization. Results: Unplanned hospitalizations occurred in 190 (29%) patients, which were associated with worse OS (adjusted hazards ratio [aHR] of 2.07, 95% confidence interval [CI] of 1.53–2.81, p < 0.001) and progression-free survival (aHR 1.83, 95% CI 1.38–2.41, p < 0.001). However, hospitalizations were not associated with LRF or DF outcomes. Similar findings were noted on 180 matched pairs as well as subgroups stratified by p16 status. In addition, when compared to patients with a prophylactic PEG tube, therapeutic PEG tube placement was associated with a higher risk of hospitalization (adjusted odds ratio [aOR] of 1.96, 95% CI 1.10–3.54, p = 0.02), while those without PEG tubes were less likely to be hospitalized (aOR 0.48, 95% CI 0.27–0.86, p = 0.01). Conclusions: Unplanned hospitalization was an independent, adverse prognostic factor for poor survival, but not oncologic outcomes. Unplanned hospitalization incidence was largely driven by those who required a therapeutic PEG tube, while it was the lowest for those who never needed a PEG tube.
Open AccessAssociation of Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement with Unplanned Hospitalization for Head and Neck Cancer
Background/Objectives: There is a varying need for nutritional support among head and neck cancer (HNC) patients. Unplanned hospitalization is frequent with definitive chemoradiation. However, the association of unplanned hospitalizations with cancer control outcomes and percutaneous endoscopic gastrostomy (PEG) tube placement is not well-understood. This study aims to evaluate the clinical outcomes stratified by unplanned hospitalizations and to identify the prognostic factors associated with unplanned hospitalizations. Methods: This retrospective cohort study included 657 HNC patients treated with definitive chemoradiation at a single institution between 2007 and 2023. Relevant clinical data were evaluated for unplanned hospitalizations, prophylactic vs. therapeutic PEG tube placement, and clinical outcomes. Multivariable, subgroup, and matched-pair analyses were performed to account for potential confounding variables. The main outcomes and measures used are overall survival (OS), progression-free survival (PFS), locoregional failure (LRF), distant failure (DF), and incidence of unplanned hospitalization. Results: Unplanned hospitalizations occurred in 190 (29%) patients, which were associated with worse OS (adjusted hazards ratio [aHR] of 2.07, 95% confidence interval [CI] of 1.53–2.81, p < 0.001) and progression-free survival (aHR 1.83, 95% CI 1.38–2.41, p < 0.001). However, hospitalizations were not associated with LRF or DF outcomes. Similar findings were noted on 180 matched pairs as well as subgroups stratified by p16 status. In addition, when compared to patients with a prophylactic PEG tube, therapeutic PEG tube placement was associated with a higher risk of hospitalization (adjusted odds ratio [aOR] of 1.96, 95% CI 1.10–3.54, p = 0.02), while those without PEG tubes were less likely to be hospitalized (aOR 0.48, 95% CI 0.27–0.86, p = 0.01). Conclusions: Unplanned hospitalization was an independent, adverse prognostic factor for poor survival, but not oncologic outcomes. Unplanned hospitalization incidence was largely driven by those who required a therapeutic PEG tube, while it was the lowest for those who never needed a PEG tube.